The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature review

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel human pathogen causing coronavirus disease 2019 (COVID-19). Rare cases of COVID-19 vaccine-induced immune thrombotic thrombocytopenia (VITT) after the ChAdOx1 nCoV-19 (AstraZeneca) vaccination have been reported. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsiao, Po-Jen, Wu, Kun-Lin, Chen, Yeu-Chin, Chen, Yen-Lin, Wang, Ruei-Lin, Wu, Kuo-An, Chan, Jenq-Shyong, Chiu, Chih-Chiun, Huang, Li-Yen, Shyu, Hann-Yen, Kao, Yung-Hsi, Chuu, Chih-Pin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839803/
https://www.ncbi.nlm.nih.gov/pubmed/35167842
http://dx.doi.org/10.1016/j.cca.2022.02.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839803/
https://www.ncbi.nlm.nih.gov/pubmed/35167842
http://dx.doi.org/10.1016/j.cca.2022.02.003

Ejemplares similares